Peter A Kiener - Net Worth and Insider Trading
Peter A Kiener Net Worth
The estimated net worth of Peter A Kiener is at least $37,035 dollars as of 2024-05-13. Peter A Kiener is the Chief Science Officer of Sucampo Pharmaceuticals Inc and owns about 2,023 shares of Sucampo Pharmaceuticals Inc (SCMP) stock worth over $36,414. Peter A Kiener is also the Director of Cue Biopharma Inc and owns about 357 shares of Cue Biopharma Inc (CUE) stock worth over $621. Details can be seen in Peter A Kiener's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter A Kiener has not made any transactions after 2023-03-23 and currently still holds the listed stock(s).
Transaction Summary of Peter A Kiener
Peter A Kiener Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter A Kiener owns 3 companies in total, including Pieris Pharmaceuticals Inc (PIRS) , Cue Biopharma Inc (CUE) , and Sucampo Pharmaceuticals Inc (SCMP) .
Click here to see the complete history of Peter A Kiener’s form 4 insider trades.
Insider Ownership Summary of Peter A Kiener
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PIRS | Pieris Pharmaceuticals Inc | 2023-06-21 | director |
CUE | Cue Biopharma Inc | 2023-03-23 | director |
SCMP | Sucampo Pharmaceuticals Inc | 2018-02-13 | Chief Science Officer |
Peter A Kiener Latest Holdings Summary
Peter A Kiener currently owns a total of 2 stocks. Among these stocks, Peter A Kiener owns 2,023 shares of Sucampo Pharmaceuticals Inc (SCMP) as of December 7, 2017, with a value of $36,414 and a weighting of 98.32%. Peter A Kiener also owns 357 shares of Cue Biopharma Inc (CUE) as of March 23, 2023, with a value of $621 and a weighting of 1.68%.
Latest Holdings of Peter A Kiener
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SCMP | Sucampo Pharmaceuticals Inc | 2017-12-07 | 2,023 | 18.00 | 36,414 |
CUE | Cue Biopharma Inc | 2023-03-23 | 357 | 1.74 | 621 |
Holding Weightings of Peter A Kiener
Peter A Kiener Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter A Kiener has made a total of 0 transactions in Sucampo Pharmaceuticals Inc (SCMP) over the past 5 years. The most-recent trade in Sucampo Pharmaceuticals Inc is the sale of 50,000 shares on December 7, 2017, which brought Peter A Kiener around $825,000.
According to the SEC Form 4 filings, Peter A Kiener has made a total of 2 transactions in Cue Biopharma Inc (CUE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Cue Biopharma Inc is the sale of 9,325 shares on March 23, 2023, which brought Peter A Kiener around $30,586.
Insider Trading History of Peter A Kiener
- 1
Peter A Kiener Trading Performance
Peter A Kiener Ownership Network
Ownership Network List of Peter A Kiener
Ownership Network Relation of Peter A Kiener
Peter A Kiener Owned Company Details
What does Pieris Pharmaceuticals Inc do?
Who are the key executives at Pieris Pharmaceuticals Inc?
Peter A Kiener is the director of Pieris Pharmaceuticals Inc. Other key executives at Pieris Pharmaceuticals Inc include 10 percent owner Bvf Gp Holdings Llc , other: See Explanation of Responses Bvf Ii Gp Llc , and 10 percent owner Bvf I Gp Llc .
Pieris Pharmaceuticals Inc (PIRS) Insider Trades Summary
Over the past 18 months, Peter A Kiener made no insider transaction in Pieris Pharmaceuticals Inc (PIRS). Other recent insider transactions involving Pieris Pharmaceuticals Inc (PIRS) include a net purchase of 10,000 shares made by Christopher P Kiritsy ,
In summary, during the past 3 months, insiders sold 0 shares of Pieris Pharmaceuticals Inc (PIRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pieris Pharmaceuticals Inc (PIRS) were sold and 125 shares were bought by its insiders, resulting in a net purchase of 125 shares.
Pieris Pharmaceuticals Inc (PIRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pieris Pharmaceuticals Inc Insider Transactions
Peter A Kiener Mailing Address
Above is the net worth, insider trading, and ownership report for Peter A Kiener. You might contact Peter A Kiener via mailing address: 40 Guest Street, Boston Ma 02135.